Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of parathyroid hormone administration in a patient with severe hypoparathyroidism caused by gain-of-function mutation of calcium-sensing receptor.

Endocrine journal - 1 Dec 2006

Shiohara Masaaki, Shiozawa Riyo, Kurata Kenji, Matsuura Hiroki, Arai Fumi, Yasuda Toshiyuki, Koike Kenichi

Abstract excerpt

Hypoparathyroidism caused by gain-of-function mutations of the calcium-sensing receptor (CaR) in the transmembrane domain is usually severe and difficult to manage. A patient with severe hypoparathyroidism, caused by CaR activating mutation F821L, was treated for 3 days (Day 1 to Day 3) with synthetic human parathyroid hormone 1-34 (teriparatide, PTH). An Ellsworth-Howard test of the patient revealed normal...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Calcium
Share to Creatinine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclic AMP

Share to Hypoparathyroidism

Share to Magnesium

Share to Parathyroid Hormone

Share to Phosphorus

Share to Receptors, Calcium-Sensing

Source

Identifiers

PMID: 16983178
DOI: 10.1507/endocrj.k06-053

Genes

PTH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of parathyroid hormone administration in a patient with severe hypoparathyroidism caused by gain-of-function mutation of calcium-sensing receptor.PMID 16983178Read ↗

Recombinant human parathyroid hormone therapy (1-34) in an adult patient with a gain-of-function mutation in the calcium-sensing receptor-a case report.Semantic proximity Read ↗

A case of gain-of-function mutation in calcium-sensing receptor: supplemental hydration is required for renal protection.Semantic proximity Read ↗

Comparison of hypocalcemic hypercalciuria between patients with idiopathic hypoparathyroidism and those with gain-of-function mutations in the calcium-sensing receptor: is it possible to differentiate the two disorders?Semantic proximity Read ↗

Marked hypercalcemia in a patient with hypocalciuric hypercalcemia without a mutation in the calcium-sensing receptor gene.Semantic proximity Read ↗

PTH(1-34) replacement therapy in a child with hypoparathyroidism caused by a sporadic calcium receptor mutation.Semantic proximity Read ↗

[Calcium receptor (CaR): a new approach to regulation of calcium homeostasis].Semantic proximity Read ↗

[Drugs inhibiting parathyroid hormone (PTH) secretion by control of the calcium receptor (calcimimetics)--effect on the set point of calcium-regulated PTH secretion].Semantic proximity Read ↗

Association of polymorphic alleles of the calcium-sensing receptor gene with parathyroid hormone secretion in hemodialysis patients.Semantic proximity Read ↗

Long-Term Results of Continuous Subcutaneous Recombinant PTH (1-34) Infusion in Children with Refractory HypoparathyroidismSemantic proximity Read ↗

[Regulation of parathyroid hormone in molecular biological aspect].Semantic proximity Read ↗

Molecular mechanisms underlying the sensing of extracellular Ca2+ by parathyroid and kidney cells.Semantic proximity Read ↗

PTH-C1: a rat continuous cell line expressing the parathyroid phenotype.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.